<DOC>
	<DOCNO>NCT02208492</DOCNO>
	<brief_summary>Unlike first generation antiepileptic medication , new drug epilepsy levetiracetam report less adverse effect child many study systematically review subject . This study aim prospectively evaluate effect levetiracetam neurocognition , behavioral issue quality life , well seizure control efficacy adverse event pediatric epilepsy patient , comparison carbamazepine , one classic antiepileptic medication , widely prescribe partial generalized seizure , despite well know side effect . This multicenter , open-label , parallel-group trial expect enroll 130 patient age 4 16 woh randomize two group , prescribe levetiracetam carbamazepine . Series neuropsychological assessment behavioral life evaluation patient perform baseline period 52 week study period .</brief_summary>
	<brief_title>The Effects Cognitive Function Levetiracetam ( Keppra® ) Compared Carbamazepine ( Tegretol® , Carmazepine® ) Monotherapy Children With Partial Seizure ; A Multicentric Randomized Controlled Study</brief_title>
	<detailed_description />
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>1 . Patients age 4 16 , diagnose focal epilepsy 2 . Patients experience minimal two unprovoked seizure , patient one unprovoked seizure show focal abnormality EEG 3 . Patients receive antiepileptic medication prior study ( Those treat rescue medication eligible ) 4 . Patients eligible consent legal guardian give official consent 1 . Patients progressive CNS disease , systemic illness 2 . Patients level SGOT/SPGT double normal level BUN/Creatinine 3 time normal range 3 . Patients use antiepileptic medication period trial , include baseline period . ( Benzodiazepine use rescue therapy acceptable ) 4 . Patients show hypersensitive reaction study medication . 5 . Patients psychological problem . 6 . Patients deem inappropriate study investigator</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Levetiracetam , Carabamazepine</keyword>
</DOC>